Conjugates of Small Molecule Drugs with Antibodies and Other Proteins

@inproceedings{Feng2014ConjugatesOS,
  title={Conjugates of Small Molecule Drugs with Antibodies and Other Proteins},
  author={Yang Feng and Zhongyu Zhu and Weizao Chen and Ponraj Prabakaran and Kedan Lin and D. S. Dimitrov},
  booktitle={Biomedicines},
  year={2014}
}
Conjugates of small molecule drugs with antibodies (ADCs) and with other proteins (protein-drug conjugates, PDC) are used as a new class of targeted therapeutics combining the specificity of monoclonal antibodies (mAbs) and other proteins with potent cytotoxic activity of small molecule drugs for the treatment of cancer and other diseases. A(P)DCs have three major components, antibody (targeting protein), linker and payload, the cytotoxic drug. Recently, advances in identifying targets… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 68 references

Highly potent and broad bispecific multivalent HIV-1 inhibitors based on human CD4 and antibody

W. Chen, Y. Feng, +7 authors V. R Polonis
domains. J. Virol • 2013
View 4 Excerpts
Highly Influenced

Antibody-drug conjugates in cancer therapy.

Annual review of medicine • 2013
View 3 Excerpts

Bioconjugate Techniques, 3rd ed.

G. T. Hermanson
2013
View 1 Excerpt

Drug-conjugated antibodies for the treatment of cancer.

British journal of clinical pharmacology • 2013
View 3 Excerpts

Similar Papers

Loading similar papers…